Tonix Pharmaceuticals Announces Exclusive Option and
New Zinc Nanoparticle (ZNP) Technology Replaces the Lipid Nanoparticle (LNP) Technology Employed in Current mRNA COVID-19 Vaccines ZNP Technology Expected...
United States Juergen Richt Waithaka Mwangi Seth Lederman Kansas State University Tonix Pharmaceuticals
Source: globenewswire.com